Recruiting African American women to participate in hereditary breast cancer research

Journal of Clinical Oncology

Volumn 23, Issue 31, 2005, Pages 7967-7973

  Halbert, Chanita Hughes ^a,b   Brewster, Kiyona ^a   Collier, Aliya ^a   Smith, ChaChira ^a   Kessler, Lisa ^a   Weathers, Benita ^a   Stopfer, Jill E ^a   Domchek, Susan ^a   Wileyto, E Paul ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AFRICAN AMERICAN; ARTICLE; BREAST CANCER; CANCER CENTER; CANCER RESEARCH; COMMUNITY CARE; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC COUNSELING; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; PATIENT REFERRAL; PRIORITY JOURNAL; ATTITUDE TO HEALTH; BREAST TUMOR; ETHNOLOGY; GENETICS; MIDDLE AGED; MUTATION; NEGRO; PATIENT SELECTION; PSYCHOLOGICAL ASPECT; RISK FACTOR; SOCIOECONOMICS; STATISTICS; TUMOR SUPPRESSOR GENE; UTILIZATION REVIEW;

AFRICAN CONTINENTAL ANCESTRY GROUP; ATTITUDE TO HEALTH; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; HUMANS; MIDDLE AGED; MUTATION; PATIENT SELECTION; REFERRAL AND CONSULTATION; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 32944474116     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.00.4952     Document Type: Article

References (27)

1. Murthy VH, Krumholz HM, Gross GP: Participation in cancer clinical trials: Race-, sex-, and aged-based disparities. JAMA 291:2720-2726, 2004
2. Ashing-Giwa K, Ganz PA, Peterson L: Quality of life of African-American and white long term breast carcinoma survivors. Cancer 85:418-426, 1999
3. Lerman C, Biesecker B, Benkendorf JL, et al: Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst 89:148-157, 1997
4. Moorman PG, Skinner CS, Evans JP, et al: Racial differences in enrollment in a cancer genetics registry. Cancer Epidemiol Biomarkers Prev 13:1349-1354, 2004
5. Gao Q, Tomlinson G, Das S, et al: Prevalence of BRCA1 and BRCA 2 mutations among clinic-based African-American families with breast cancer. Hum Genet 107:186-191, 2000
6. Thompson HS, Valdimarsdottir HB, Duteau-Buck C, et al: Psychological predictors of BRCA counseling and testing decisions among urban African-American women. Cancer Epidemic-1 Biomarkers Prev 11:1579-1585, 2002
7. Ramirez AG, McDonald P, Chapa M, et al: Minority recruitment to clinical trials. Presented at the Cancer Genetics Network Steering Committee Meeting, Reston, VA, April 23-24, 2002
8. Brown BA, Long HL, Gould H, et al: A conceptual model for the recruitment of diverse women into research studies. J Womens Health Gend Based Med 9:625-632, 2000
9. Schuette JL, Bennett R: Lessons in history: Obtaining the family history and constructing the pedigree, in Baker DL, Schuette JL, Uhlmann W (eds): A Guide to Genetic Counseling. Hoboken, NJ, Wiley-Liss, 1998, pp 27-54
10. American Society of Clinical Oncology: Policy statement update: Genetic testing for cancer susceptibility. J Clin Oncol 21:2397-2406, 2003
11. Frank TS, Deffenbaugh AM, Reid J, et al: Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: Analysis of 10,000 individuals. J Clin Oncol 20:1480-1490, 2002
12. Couch FJ, DeShano ML, Blackwood MA, et al: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336:1409-1415, 1997
13. Parmigiani G, Berry D, Anguilar O: Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62:145-158, 1998
14. Domchek SM, Eisen A, Calzone K, et al: Application of breast cancer risk prediction models in clinical practice. J Clin Oncol 21:593-601, 2003
15. Lerman C, Hughes C, Benkendorf JL, et al: Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiol Biomarkers Prev 8:361-376, 1999
16. Lerman C, Daly M, Masny A, et al: Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 12:843-850, 1994
17. Miki Y, Swensen J, Shattuck-Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71, 1994
18. Wooster R, Bignell G, Lancaster J, et al: Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792, 1995
19. Claus EB, Schildkraut JM, Thompson WD, et al: The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318-2324, 1996
20. Furr LA: Perceptions of genetics research as harmful to society: Differences among samples of African Americans and European Americans. Genet Test 6:25-30, 2002
21. Thompson HS, Valdimarsdottir B, Jandorf L, et al: Perceived disadvantages and concerns about abuses of genetic testing for cancer risk: Differences across African American, Latina and Caucasian women. Patient Educ Couns 51:217-227, 2003
22. Lerman C, Narod S, Schulman K, et al: BRCA1 testing in families with hereditary breast-ovarian cancer. JAMA 275:1885-1892, 1996
23. Cappelli ML, Surh L, Humphreys S, et al: Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer. Clin Genet 55:419-430, 1999
24. Hughes C, Fasaye GA, LaSalle VH, et al: Socioculturel influences on participation in genetic risk assessment and testing among African American women. Patient Educ Couns 51:107-114, 2003
25. Sears SR, Stanton AL, Kwan L, et al: Recruitment and retention challenges in breast cancer survivorship research: Results from a multisite, randomized intervention trial in women with early stage breast cancer. Cancer Epidemiol Biomarkers Prev 12:1087-1090, 2003
26. Mouchawar J, Klein CE, Mullineaux L: Colorado family physicians' knowledge of hereditary breast cancer and related practice. J Cancer Educ 16:33-37, 2001
27. Freedman AN, Wideroff L, Olson L, et al: US physicians' attitudes toward genetic testing for cancer susceptibility. Am J Med Genet 120: 63-71, 2003